An Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral Molidustat in Peritoneal Dialysis Subjects With Renal Anemia
Phase of Trial: Phase III
Latest Information Update: 16 Aug 2019
Price : $35 *
At a glance
- Drugs Molidustat (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms MIYABI PD
- Sponsors Bayer
- 14 Aug 2019 Status changed from active, no longer recruiting to completed.
- 18 Nov 2018 Planned End Date changed from 9 Nov 2019 to 31 Aug 2019.
- 18 Nov 2018 Planned primary completion date changed from 5 Oct 2019 to 31 Jul 2019.